Page last updated: 2024-12-10

dehydroretinal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

all-trans-dehydroretinal : A retinal which contains an additional double bond between the 3 and 4 positions of the six-membered ring, and in which all of the double bonds in the side chain have the E-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280866
CHEBI ID28537
SCHEMBL ID617498
MeSH IDM0067753

Synonyms (33)

Synonym
(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)nona-2,4,6,8-tetraenal
CHEBI:28537
all-trans-3,4-didehydroretinal
LMPR01090006
dehydroretinaldehyde
all-trans-3-dehydroretinal
trans-3-dehydroretinal
dehydroretinal
all-trans-3,4-dehydroretinal
retinene 2
C05918
alpha-retinene
(all-e)-3,7-dimethyl-9-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2,4,6,8-nonatetraenal
3-dehydroretinal
3-dehydroretinaldehyde
dehydroretinaldehyd
all-trans-dehydroretinal
3,4-didehydroretinal
472-87-7
vitamin a2 aldehyde
unii-hv8t003xo1
einecs 207-457-7
hv8t003xo1 ,
3-dehydro retinal
3-dehydroretinal, all-trans-
2,4,6,8-nonatetraenal, 3,7-dimethyl-9-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-, (all-e)-
retinal 2
3-dehydroretinal [mi]
SCHEMBL617498
didehydroretinal
retinene2
Q5252392
DTXSID30878517

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" This study followed DR appearance and clearance after dosage in serum and milk during 2 lactation cycles in sows (n = 8) fed VA-free feed for 3 gestation-lactation cycles."( 3, 4-Didehydroretinol kinetics differ during lactation in sows on a retinol depletion regimen and the serum:milk 3, 4-didehydroretinol:retinol ratios are correlated.
Hutson, PR; Mills, JP; Surles, RL; Tanumihardjo, SA; Valentine, AR, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
retinals
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (71.43)18.7374
1990's2 (7.14)18.2507
2000's4 (14.29)29.6817
2010's2 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.17 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]